Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer

By Schroeder Richard L.   Stevens Cheryl L.   Sridhar Jayalakshmi  

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 15196-15212

MDPI

Access to resources Recommend Favorite

Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors

By Olivero-Acosta Maria   Maldonado-Rojas Wilson   Olivero-Verbel Jesus  

Molecules, Vol. 22, Iss. 2, 2017-02 ,pp. : 308-308

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics

By Hervent Anne-Sophie   De Keulenaer Gilles W.  

International Journal of Molecular Sciences, Vol. 13, Iss. 10, 2012-09 ,pp. : 12268-12286

MDPI

Access to resources Recommend Favorite

Synthesis and Evaluation of Novel 2-Pyrrolidone-Fused (2-Oxoindolin-3-ylidene)methylpyrrole Derivatives as Potential Multi-Target Tyrosine Kinase Receptor Inhibitors

By Yang Ting-Hsuan   Lee Chun-I   Huang Wen-Hsin   Lee An-Rong  

Molecules, Vol. 22, Iss. 6, 2017-05 ,pp. : 913-913

MDPI

Access to resources Recommend Favorite

Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer

By Quan Jinhua   Yahata Tetsuro   Adachi Sosuke   Yoshihara Kosuke   Tanaka Kenichi  

International Journal of Molecular Sciences, Vol. 12, Iss. 2, 2011-01 ,pp. : 971-982

MDPI

Access to resources Recommend Favorite